Previous Close | 788.00 |
Open | 779.50 |
Bid | 803.50 x 0 |
Ask | 804.00 x 0 |
Day's Range | 773.00 - 804.50 |
52 Week Range | 274.40 - 972.00 |
Volume | |
Avg. Volume | 274,347 |
Market Cap | 57.04B |
Beta (5Y Monthly) | 0.55 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -11.50 |
Earnings Date | Nov 07, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 978.29 |
The future of the weight loss market might not revolve around GLP-1 drugs.
Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s designed to work differently from those currently on the market and with the potential for fewer side effects.